Moreover, recent data obtained from cerebrospinal fluid samples of human subjects not only demonstrated a robust negative regulatory relationship between miRNA 132 and its confirmed target AChE, but diminished miRNA 132 and heightened AChE levels were also associated with the development of post-stroke dementia [77]. The gene discussed is ACHE; the disease is dementia.